Un problème de pratique quotidienne: l'allongement du temps de céphaline-activateur = A practical everyday problem: increased cephalin activator timeDROUET, L.STV. Sang thrombose vaisseaux. 1993, Vol 5, Num 9, pp 647-649, issn 0999-7385Article

Measurement of activated clotting time in children: comparison of the Celite i-STAT® ACT with the Medtronic ACT® IIHUG, H. I; DI BERNARDO, S; BERGER, F et al.Acta anaesthesiologica scandinavica. 2004, Vol 48, Num 2, pp 211-217, issn 0001-5172, 7 p.Article

Aprotinin does not prolong the sonoclot aprotinin-insensitive activated clotting timeYUE DONG; NUTTALL, Gregory A; OLIVER, William C et al.Journal of clinical anesthesia. 2007, Vol 19, Num 6, pp 424-428, issn 0952-8180, 5 p.Article

Impact of different Asian ethnic groups on correlation between heparin dose, activated clotting time and complications in percutaneous coronary interventionLEE, Chi-Hang; TAN, Esther; WONG, Hwee-Bee et al.International journal of cardiology. 2008, Vol 130, Num 3, pp 500-502, issn 0167-5273, 3 p.Article

Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgeryNILES, S. D; SUTTON, R. G; PLOESSL, J et al.The Journal of extra-corporeal technology. 1995, Vol 27, Num 4, pp 197-200, issn 0022-1058Conference Paper

Factors affecting the activated clotting timeKASE, P. B; DEARING, J. P.The Journal of extra-corporeal technology. 1985, Vol 17, Num 1, pp 27-30, issn 0022-1058Article

Neutralization of heparin using a protamine titration assay and the activated clotting time testLADUCA, F; MILLS, D; THOMPSON, S et al.The Journal of extra-corporeal technology. 1987, Vol 19, Num 3, pp 358-364, issn 0022-1058Conference Paper

Monitoring activated clotting time for combined heparin and aprotinin application : in vivo evaluation of a new aprotinin-insensitive test using sonoclotCANTER, Michael T; MONN, Antoinette; TAVAKOLI, Reza et al.European journal of cardio-thoracic surgery. 2006, Vol 30, Num 2, pp 278-284, issn 1010-7940, 7 p.Article

Activated clotting time or activated partial thromboplastin time as the method of choice for patients undergoing neuroradiological interventionKUBALEK, R; BERLIS, A; SCHWAB, M et al.Neuroradiology (Berlin. Print). 2003, Vol 45, Num 5, pp 325-327, issn 0028-3940, 3 p.Article

How much heparin do we really need to go on pump? A rethink of current practices. DiscussionSHUHAIBAR, M. N; HARGROVE, M; MILLAT, M. H et al.European journal of cardio-thoracic surgery. 2004, Vol 26, Num 5, pp 947-950, issn 1010-7940, 4 p.Article

In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulationLINKINS, Lori-Ann; JULIAN, Jim A; RISCHKE, Janice et al.Thrombosis research. 2002, Vol 107, Num 5, pp 241-244, issn 0049-3848, 4 p.Article

APPARATUS : Validation of a bedside activated clotting time test (Hemochron® Jr II Signature) with low dose heparin therapyRACIOPPI, L; QUINART, A; BIAIS, M et al.Anaesthesia. 2009, Vol 64, Num 4, pp 430-434, issn 0003-2409, 5 p.Article

New technology, old standards: Disparate activated clotting time measurements by the Hemochron Jr compared with the standard HemochronAYLSWORTH, Christopher L; STEFAN, Faith; WOITAS, Karl et al.The Annals of thoracic surgery. 2004, Vol 77, Num 3, pp 973-976, issn 0003-4975, 4 p.Article

Validation of the i-STAT handheld activated clotting time for use with BivalirudinSCHUSSLER, Jeffrey M; LANDER, Stuart R; WISSINGER, Laurie A et al.The American journal of cardiology. 2004, Vol 93, Num 10, pp 1318-1319, issn 0002-9149, 2 p.Article

In vivo demonstration of an antithrombin effect of AbciximabAMBROSE, J. A; HAWKEY, M; DOSS, R et al.The American journal of cardiology. 2000, Vol 86, Num 2, pp 150-152, issn 0002-9149Article

New insights into how blood clots : Implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapyBAJAJ, S. P; JOIST, J. H.Seminars in thrombosis and hemostasis. 1999, Vol 25, Num 4, pp 407-418, issn 0094-6176Article

Les tests délocalisés auprès du malade pour adapter les traitements anticoagulants oraux = Delocalised patient testing for controling oral anticoagulant therapyTRIPODI, A; DROUET, L.STV. Sang thrombose vaisseaux. 1998, Vol 10, Num 7, pp 404-407, issn 0999-7385Article

Effect of hemodilution with dextran and albumin on activated clotting time (ACT)INOUE, M; HIROSE, Y; GAMOU, M et al.Masui. 1997, Vol 46, Num 6, pp 809-812, issn 0021-4892Article

The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT)BODE, A. P; CASTELLANI, W. J; HODGES, E. D et al.Thrombosis and haemostasis. 1991, Vol 66, Num 2, pp 213-217, issn 0340-6245Article

Activated clotting time (ACT): the reproducibility of three techniquesSILLICK, P. V; AMIOT, D. M; PANCNER, G et al.The Journal of extra-corporeal technology. 1987, Vol 19, Num 3, pp 265-267, issn 0022-1058Conference Paper

Zur Steuerung der temporären Antikoagulation während des extrakorporalen Kreislaufs mit Hilfe der aktivierten Gerinnungszeit = Contrôle de l'anticoagulation temporaire au cours de la circulation extracorporelle à l'aide du temps de coagulation activé = Control of temporary anticoagulation during extracorporal circulation with the activated clotting timeKESSLER, G; GRÜNES, G.Der Anaesthesist (Berlin. Print). 1984, Vol 33, Num 12, pp 588-591, issn 0003-2417Article

Validation of a new whole blood coagulation monitoring systemJARYNO, Stacy; BENNETT, Kim; LODER, Carol et al.The Journal of extra-corporeal technology. 2002, Vol 34, Num 4, pp 271-275, issn 0022-1058, 5 p.Conference Paper

Anticoagulant management in interventional cardiology : Monitoring heparin using act instrumentationOGILBY, J. D; CARVILLE, D. G. M.Cardiovascular reviews & reports. 1998, Vol 19, Num 11, pp 34-47, issn 0197-3118, 7 p.Article

Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patientsJIAN-SHENG WANG; CHUNG-YUAN LIN; KARP, R. B et al.Anesthesia and analgesia. 1994, Vol 79, Num 1, pp 9-13, issn 0003-2999Article

In vitro effects of aprotinin on activated clotting time measured with different activatorsJIAN-SHENG WANG; CHUNG-YUAN LIN; WEI-TE HUNG et al.Journal of thoracic and cardiovascular surgery. 1992, Vol 104, Num 4, pp 1135-1140, issn 0022-5223Article